# TWIST1

## Overview
TWIST1 is a gene located on human chromosome 7p21 that encodes the twist family basic helix-loop-helix (bHLH) transcription factor 1. This transcription factor is pivotal in embryonic development, influencing processes such as mesoderm formation and cranial suture development. The TWIST1 protein functions primarily by binding to specific DNA sequences and regulating the transcription of genes involved in development and differentiation. It can form both homodimers and heterodimers, which allows it to control a diverse array of developmental pathways. Mutations in the TWIST1 gene are associated with several developmental disorders, most notably Saethre-Chotzen syndrome, and its dysregulation is implicated in various cancers due to its role in the epithelial-mesenchymal transition (EMT) (Qin2011Normal; Franco2010Redundant).

## Structure
The TWIST1 protein, encoded by the TWIST1 gene, is a basic helix-loop-helix (bHLH) transcription factor that plays a crucial role in embryological development. The protein is composed of 202 amino acids and includes distinct structural domains crucial for its function. The primary structure of TWIST1 features a highly conserved bHLH domain spanning amino acids 108-164, essential for DNA binding and dimerization. This domain forms a structure with two amphipathic Î±-helices separated by a loop, facilitating the formation of homo- or heterodimers which are essential for its transcriptional regulatory functions (Maia2012Computational; Bouard2017Destabilization).

The N-terminal and C-terminal regions of TWIST1 are characterized by their intrinsically disordered nature, providing flexibility that is crucial for protein-protein interactions. The N-terminal region, particularly the first 12 amino acids, contains motifs predicted to have protein-binding potential, such as the SSSPVSP sub-motif (Rodriguez2016Evolution). The C-terminal region includes a 'twist-box' and WR motif, interspersed with Î±-helix domains, contributing to the protein's modular structure (Maia2012Computational).

Post-translational modifications of TWIST1, such as phosphorylation, play significant roles in regulating its activity and stability. Specific kinases like GSK3 target serine residues within the N-terminal region, influencing the protein's function and interactions (Rodriguez2016Evolution).

Overall, the molecular structure of TWIST1, including its disordered regions and conserved bHLH domain, is integral to its function as a transcription factor, impacting its ability to bind DNA and interact with other proteins.

## Function
TWIST1, a basic helix-loop-helix (bHLH) transcription factor, plays a pivotal role in various stages of embryonic development by regulating gene expression crucial for cell differentiation and organogenesis. It functions by binding to E-box sequences in DNA, either as homodimers or heterodimers with other bHLH proteins, influencing the transcriptional outcomes based on these interactions (Zhu2015The; Franco2010Redundant). The balance between homodimer and heterodimer formations is regulated by factors such as Id proteins and posttranslational modifications like phosphorylation, which affect TWIST1's function in transcriptional regulation (Zhu2015The; Franco2010Redundant).

In the context of mesoderm development, TWIST1 is essential for specifying mesodermal tissues during embryogenesis. It is highly expressed in mesoderm-derived embryonic mesenchyme and regulates genes involved in mesoderm specification and differentiation (Qin2011Normal). TWIST1 also plays a critical role in cranial suture development by interacting with other transcription factors like Runx2 to modulate osteoblast differentiation, which is crucial for cranial bone formation (Franco2010Redundant).

Moreover, TWIST1 is involved in the epithelial-mesenchymal transition (EMT), a process vital for embryonic development and wound healing. It promotes EMT by repressing E-cadherin, a key molecule in maintaining epithelial cell phenotype, and by regulating other molecular signals that induce cellular changes necessary for EMT (Zhu2015The). This function underscores TWIST1's role in facilitating cell migration and invasion, processes essential for normal development and pathological conditions such as cancer metastasis.

## Clinical Significance
TWIST1 mutations are predominantly linked to Saethre-Chotzen syndrome (SCS), a condition characterized by craniosynostosis, facial asymmetry, and limb anomalies. This autosomal dominant disorder exhibits variable expression and incomplete penetrance, with mutations often resulting in haploinsufficiency, which disrupts the transcriptional activity of TWIST1 by impacting protein kinase A-mediated phosphorylation (Kress2005SaethreâChotzen; Miraoui2010Pivotal). The mutations, including missense and nonsense mutations, typically occur in the basic helix-loop-helix (bHLH) domain of TWIST1, crucial for DNA binding and dimerization (Paznekas1998Genetic). These genetic alterations lead to a range of phenotypic expressions such as unilateral or bilateral coronal synostosis, ptosis, and syndactyly (Altiner2017A).

In addition to craniosynostosis syndromes, TWIST1's role extends to cancer biology, where its dysregulation is associated with tumor progression and metastasis. Overexpression of TWIST1 has been observed in various cancers, including breast cancer and hepatocellular carcinoma, promoting epithelial-mesenchymal transition (EMT), a key process in cancer metastasis. This overexpression leads to the repression of E-cadherin, enhancing cell motility and invasiveness (Qin2011Normal). Furthermore, TWIST1 interacts with other pathways and factors, such as STAT3 and AKT2, to promote oncogenic functions and resistance to chemotherapy (Qin2011Normal).

Overall, the clinical significance of TWIST1 spans from developmental disorders like SCS to critical roles in cancer progression, highlighting its importance in both genetic disease and oncology.

## Interactions
TWIST1, a basic helix-loop-helix (bHLH) transcription factor, engages in various protein-protein interactions that are crucial for its role in transcriptional regulation and developmental processes. It forms heterodimers with other bHLH transcription factors such as E12 and E47, enhancing its DNA-binding capabilities (Qin2011Normal). Additionally, TWIST1 interacts with MyoD, another bHLH transcription factor, inhibiting MyoD and MEF2 functions which are essential for muscle differentiation (Qin2011Normal). The N-terminal region of TWIST1 is known to interact with chromatin regulators including CHD7, CHD8, and WHSC1, suggesting a role in chromatin organization and transcription regulation (Fan2020TWIST1a). Furthermore, TWIST1's interaction with the tumor suppressor p53 involves binding to p53's DNA-binding domain, inhibiting p53's transcriptional activities (Shiota2008Twist). The WR domain of TWIST1 also mediates interactions with the NFÎºB subunit p65 and the C-terminus of p53, influencing transcriptional regulation and p53 degradation, respectively (Roberts2017Disruption). These interactions highlight TWIST1's multifaceted role in regulating gene expression and influencing developmental and pathological processes.


## References


[1. (Fan2020TWIST1a) TWIST1 and chromatin regulatory proteins interact to guide neural crest cell differentiation (35 citations) 10.1101/2020.09.06.285387](https://doi.org/10.1101/2020.09.06.285387)

[2. (Zhu2015The) Qing-Qing Zhu, Chenhui Ma, Qian Wang, Yong Song, and Tangfeng Lv. The role of twist1 in epithelial-mesenchymal transition and cancers. Tumor Biology, 37(1):185â197, November 2015. URL: http://dx.doi.org/10.1007/s13277-015-4450-7, doi:10.1007/s13277-015-4450-7. (193 citations) 10.1007/s13277-015-4450-7](https://doi.org/10.1007/s13277-015-4450-7)

[3. (Qin2011Normal) Qian Qin, Young Xu, Tao He, Chunlin Qin, and Jianming Xu. Normal and disease-related biological functions of twist1 and underlying molecular mechanisms. Cell Research, 22(1):90â106, August 2011. URL: http://dx.doi.org/10.1038/cr.2011.144, doi:10.1038/cr.2011.144. (529 citations) 10.1038/cr.2011.144](https://doi.org/10.1038/cr.2011.144)

[4. (Bouard2017Destabilization) Charlotte Bouard, Raphael Terreux, AgnÃ¨s Tissier, Laurent Jacqueroud, Arnaud Vigneron, StÃ©phane Ansieau, Alain Puisieux, and LÃ©a Payen. Destabilization of the twist1/e12 complex dimerization following the r154p point-mutation of twist1: an in silico approach. BMC Structural Biology, May 2017. URL: http://dx.doi.org/10.1186/s12900-017-0076-x, doi:10.1186/s12900-017-0076-x. (8 citations) 10.1186/s12900-017-0076-x](https://doi.org/10.1186/s12900-017-0076-x)

[5. (Franco2010Redundant) H. L. Franco, J. Casasnovas, J. R. Rodriguez-Medina, and C. L. Cadilla. Redundant or separate entities?âroles of twist1 and twist2 as molecular switches during gene transcription. Nucleic Acids Research, 39(4):1177â1186, October 2010. URL: http://dx.doi.org/10.1093/nar/gkq890, doi:10.1093/nar/gkq890. (204 citations) 10.1093/nar/gkq890](https://doi.org/10.1093/nar/gkq890)

[6. (Paznekas1998Genetic) William A. Paznekas, Michael L. Cunningham, Timothy D. Howard, Bruce R. Korf, Mark H. Lipson, Art W. Grix, Murray Feingold, Rosalie Goldberg, Zvi Borochowitz, Kirk Aleck, John Mulliken, Mingfei Yin, and Ethylin Wang Jabs. Genetic heterogeneity of saethre-chotzen syndrome, due to twist and fgfr mutations. The American Journal of Human Genetics, 62(6):1370â1380, June 1998. URL: http://dx.doi.org/10.1086/301855, doi:10.1086/301855. (175 citations) 10.1086/301855](https://doi.org/10.1086/301855)

[7. (Altiner2017A) Åule Altiner, Halil G. Karabulut, Kanay YararbaÅ, Ajlan TÃ¼kÃ¼n, Corinne Collet, Pinar Kocaay, Merih BerberoÄlu, and Hatice Ilgin Ruhi. A novel twist1 gene mutation in a patient with saethreâchotzen syndrome. Clinical Dysmorphology, 26(3):175â178, July 2017. URL: http://dx.doi.org/10.1097/mcd.0000000000000162, doi:10.1097/mcd.0000000000000162. (7 citations) 10.1097/mcd.0000000000000162](https://doi.org/10.1097/mcd.0000000000000162)

[8. (Shiota2008Twist) M Shiota, H Izumi, T Onitsuka, N Miyamoto, E Kashiwagi, A Kidani, G Hirano, M Takahashi, S Naito, and K Kohno. Twist and p53 reciprocally regulate target genes via direct interaction. Oncogene, 27(42):5543â5553, May 2008. URL: http://dx.doi.org/10.1038/onc.2008.176, doi:10.1038/onc.2008.176. (148 citations) 10.1038/onc.2008.176](https://doi.org/10.1038/onc.2008.176)

[9. (Miraoui2010Pivotal) Hichem Miraoui and Pierre J. Marie. Pivotal role of twist in skeletal biology and pathology. Gene, 468(1â2):1â7, November 2010. URL: http://dx.doi.org/10.1016/j.gene.2010.07.013, doi:10.1016/j.gene.2010.07.013. (96 citations) 10.1016/j.gene.2010.07.013](https://doi.org/10.1016/j.gene.2010.07.013)

[10. (Kress2005SaethreâChotzen) Wolfram Kress, Christian Schropp, Gabriele Lieb, Birgit Petersen, Maria BÃ¼sse-Ratzka, JÃ¼rgen Kunz, Edeltraut Reinhart, Wolf-Dieter SchÃ¤fer, Johanna Sold, Florian Hoppe, Jan Pahnke, Andreas Trusen, Niels SÃ¶rensen, JÃ¼rgen Krauss, and Hartmut Collmann. Saethreâchotzen syndrome caused by twist 1 gene mutations: functional differentiation from muenke coronal synostosis syndrome. European Journal of Human Genetics, 14(1):39â48, October 2005. URL: http://dx.doi.org/10.1038/sj.ejhg.5201507, doi:10.1038/sj.ejhg.5201507. (166 citations) 10.1038/sj.ejhg.5201507](https://doi.org/10.1038/sj.ejhg.5201507)

[11. (Maia2012Computational) Amanda M Maia, JoÃ£o HM da Silva, AndrÃ© L Mencalha, Ernesto R Caffarena, and Eliana Abdelhay. Computational modeling of the bhlh domain of the transcription factor twist1 and r118c, s144r and k145e mutants. BMC Bioinformatics, July 2012. URL: http://dx.doi.org/10.1186/1471-2105-13-184, doi:10.1186/1471-2105-13-184. (28 citations) 10.1186/1471-2105-13-184](https://doi.org/10.1186/1471-2105-13-184)

[12. (Roberts2017Disruption) Cai M. Roberts, Sophia A. Shahin, Joana Loeza, Thanh H. Dellinger, John C. Williams, and Carlotta A. Glackin. Disruption of twist1-rela binding by mutation and competitive inhibition to validate the twist1 wr domain as a therapeutic target. BMC Cancer, March 2017. URL: http://dx.doi.org/10.1186/s12885-017-3169-9, doi:10.1186/s12885-017-3169-9. (10 citations) 10.1186/s12885-017-3169-9](https://doi.org/10.1186/s12885-017-3169-9)

[13. (Rodriguez2016Evolution) Yacidzohara Rodriguez, Ricardo R. Gonzalez-Mendez, and Carmen L. Cadilla. Evolution of the twist subfamily vertebrate proteins: discovery of a signature motif and origin of the twist1 glycine-rich motifs in the amino-terminus disordered domain. PLOS ONE, 11(8):e0161029, August 2016. URL: http://dx.doi.org/10.1371/journal.pone.0161029, doi:10.1371/journal.pone.0161029. (10 citations) 10.1371/journal.pone.0161029](https://doi.org/10.1371/journal.pone.0161029)